Company Filing History:
2 out of 1,575 
1 out of 4 Years Active: 2022
Title: The Innovative Contributions of Han-Byoel Lee
Introduction
Han-Byoel Lee is a prominent inventor based in Gangnam-gu, South Korea. He has made significant strides in the field of cancer research, particularly focusing on triple-negative breast cancer. His work aims to enhance the quality of life for patients through personalized treatment methods.
Latest Patents
Han-Byoel Lee holds a patent for a biomarker that measures the response and prognosis of triple-negative breast cancer to anticancer agents. This biomarker is capable of predicting therapeutic responses and allows for optimized personal therapeutic methods. The innovation contributes to the quality and prolongation of life for patients suffering from this aggressive form of cancer.
Career Highlights
Throughout his career, Han-Byoel Lee has been associated with notable institutions such as Seoul National University and the Industry-Academic Cooperation Foundation of Sunchon National University. His work in these organizations has furthered research and development in cancer treatment.
Collaborations
Han-Byoel Lee has collaborated with esteemed colleagues, including Wonshik Han and Dong-Young Noh. These partnerships have played a crucial role in advancing his research and innovations.
Conclusion
Han-Byoel Lee's contributions to cancer research, particularly through his patented biomarker, highlight his commitment to improving patient outcomes. His work exemplifies the importance of innovation in the medical field.